Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2025. Start Trial.
Date Value
September 30, 2026 1.517M
June 30, 2026 -4.456M
March 31, 2026 6.00M
December 31, 2025 11.13M
Date Value
September 30, 2025 14.38M
June 30, 2025 5.083M
March 31, 2025 -20.64M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Anavex Life Sciences Corp. 0.00
Vaxcyte, Inc. 170.77M
Foghorn Therapeutics, Inc. 24.19M
Caribou Biosciences, Inc. 19.39M
Oncolytics Biotech, Inc. -0.0069M